Did you know that prostate cancer is the most common cancer in Australian men, with more than 18,000 new cases estimated in 2021¹? One in six men will be diagnosed with prostate cancer by the age of 85.²

When diagnosed early, prostate cancer is curable, and 95% of patients diagnosed with prostate cancer are expected to survive at least five years after diagnosis¹. Thankfully, prostate cancer is usually slow-growing in its early stages, and can be monitored by your doctor without interventions.

However, prostate cancer that spreads to other organs (metastatic prostate cancer), most commonly the bone and lymph nodes, have poor prognosis. This cancer is the second most common cause of cancer death among males in Australia with more than 3,000 Australian men dying from prostate cancer each year.³ 

Therefore, it is important for researchers to understand the way that prostate cancer spreads (metastasises), to develop strategies to prevent it.

OUR RESEARCH FOCUS

• identify how high cell membrane cholesterol promotes prostate cancer spreading
• develop liquid biopsy tests for active surveillance of prostate cancer

ASSOCIATED LABS

• Precision & Systems Biomedicine

SOURCES

1. Cancer Australia – https://www.cancer.org.au/cancer-information/types-of-cancer/prostate-cancer 
2. Cancer Council
3. AIHW Cancer Data in Australia
4. Cancer Australia